R&G PharmaStudies Co., Ltd. Class A

R&G PharmaStudies Co., Ltd. Class A

SSZSE:301333
51.05
CNY
-0.54
(-1.05%)
1.25EPS
54.63P/E
6.44BMarket Cap
Mar 29Next Earn

Latest Stock Split

Jun 29, 2023

8:5

For every 5 shares held, investors received 8. The price per share adjusted from $83.70 to $52.31.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Jun 29, 2023
    Before$83.70
    Split ratio8:5
    After$52.31
    Forward

About R&G PharmaStudies Co., Ltd. Class A stock splits

R&G PharmaStudies Co., Ltd. Class A (SZSE:301333) operates in the Biotechnology industry.

R&G PharmaStudies Co., Ltd. Class A company overview

When did R&G PharmaStudies Co., Ltd. Class A stock split?

R&G PharmaStudies Co., Ltd. Class A's most recent stock split was on June 29, 2023. It was a 8-for-5 forward split, so shareholders received 8 shares for every 5 they held.

How many times has R&G PharmaStudies Co., Ltd. Class A stock split?

R&G PharmaStudies Co., Ltd. Class A has split its stock once. This history records one forward split, on June 29, 2023.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In R&G PharmaStudies Co., Ltd. Class A's 8-for-5 split on June 29, 2023, every 5 shares became 8 shares.

Will R&G PharmaStudies Co., Ltd. Class A split its stock again?

R&G PharmaStudies Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on June 29, 2023, 3 years ago. Companies announce splits in advance, and any new SZSE:301333 split will appear on this page.